<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Breast Cancer Neoadjuvant Chemotherapy Treatment Response Prediction Using Aligned Longitudinal MRI and Clinical Data - Health AI Hub</title>
    <meta name="description" content="This study developed machine learning models to predict pathologic complete response (PCR) and 5-year relapse-free survival (RFS) in breast cancer patients unde">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Breast Cancer Neoadjuvant Chemotherapy Treatment Response Prediction Using Aligned Longitudinal MRI and Clinical Data</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.17759v1" target="_blank">2512.17759v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-19
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Rahul Ravi, Ruizhe Li, Tarek Abdelfatah, Stephen Chan, Xin Chen
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> eess.IV, cs.CV, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.17759v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.17759v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This study developed machine learning models to predict pathologic complete response (PCR) and 5-year relapse-free survival (RFS) in breast cancer patients undergoing neoadjuvant chemotherapy (NACT), utilizing longitudinal contrast-enhanced MRI and clinical data. The research demonstrated that an image registration-based approach significantly enhanced feature extraction from MRI, and that radiomic features, particularly with logistic regression, outperformed deep learning-based features for these prognostic predictions.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate prediction of NACT response and long-term survival in breast cancer patients is critical for personalizing treatment strategies. This research provides a data-driven approach that could help clinicians identify patients most likely to achieve a pathologic complete response or those at higher risk of relapse, thereby enabling tailored therapeutic decisions and improving patient outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The research applies machine learning and deep learning models (including radiomics and various neural networks) to predict breast cancer treatment response (pathologic complete response and 5-year relapse-free survival) based on longitudinal MRI scans and clinical data. This AI application aims to provide clinicians with predictive tools to personalize treatment strategies, assess prognosis, and optimize patient management for breast cancer.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>The primary aim was to predict NACT treatment response (PCR and 5-year RFS, both binary classifications) in breast cancer patients using longitudinal CE-MRI and clinical data.</li>
                    
                    <li>The proposed framework included tumour segmentation, image registration, feature extraction, and predictive modelling, with image registration crucial for monitoring intratumoral changes over time.</li>
                    
                    <li>Four feature extractors were compared: one radiomics-based and three deep learning-based (MedicalNet, Segformer3D, SAM-Med3D), in combination with three feature selection methods and four machine learning models.</li>
                    
                    <li>The image registration method consistently improved the performance of the predictive models by enabling effective longitudinal feature learning.</li>
                    
                    <li>The logistic regression model, trained on radiomic features, demonstrated the best performance for both prediction tasks.</li>
                    
                    <li>For PCR classification, the best model achieved an AUC of 0.88 and a classification accuracy of 0.85.</li>
                    
                    <li>For RFS classification, the best model achieved an AUC of 0.78 and a classification accuracy of 0.72, with radiomics features being more effective and interpretable than pre-trained deep learning features.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employed a comprehensive framework involving processing longitudinal contrast-enhanced MRI and clinical data. Key steps included tumour segmentation, followed by image registration to align images at different time points for precise tracking of intratumoral changes. Four feature extraction methods were compared: a traditional radiomics approach and three deep learning models (MedicalNet, Segformer3D, SAM-Med3D). These extracted features were then subjected to three feature selection methods and subsequently used to train four different machine learning models for binary classification of PCR and RFS. Model performance was evaluated using Area Under the Curve (AUC) and classification accuracy.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The study's key findings are: 1) The implementation of an image registration method significantly and consistently improved the predictive capabilities of models by facilitating robust longitudinal feature learning. 2) For both pathologic complete response (PCR) and relapse-free survival (RFS) prediction, the logistic regression model, utilizing radiomic features, achieved superior performance. 3) Specifically, for PCR, this model yielded an AUC of 0.88 and an accuracy of 0.85, while for RFS, it achieved an AUC of 0.78 and an accuracy of 0.72. 4) Radiomics features were found to be more effective and provided better interpretability compared to the pre-trained deep learning feature extractors in this context.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research offers a promising non-invasive prognostic tool that could enable clinicians to more accurately predict breast cancer patients' response to neoadjuvant chemotherapy and their 5-year relapse-free survival. Such predictions could inform individualized treatment plans, potentially guiding decisions on surgical de-escalation for strong responders, or prompting alternative, more aggressive therapies for those predicted to have a poor response, thus optimizing patient care and reducing treatment-related morbidities.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the study.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly suggest any future research directions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                    <span class="tag">Pathology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Breast Cancer</span>
                    
                    <span class="tag tag-keyword">Neoadjuvant Chemotherapy</span>
                    
                    <span class="tag tag-keyword">MRI</span>
                    
                    <span class="tag tag-keyword">Image Registration</span>
                    
                    <span class="tag tag-keyword">Radiomics</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">PCR Prediction</span>
                    
                    <span class="tag tag-keyword">RFS Prediction</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Aim: This study investigates treatment response prediction to neoadjuvant chemotherapy (NACT) in breast cancer patients, using longitudinal contrast-enhanced magnetic resonance images (CE-MRI) and clinical data. The goal is to develop machine learning (ML) models to predict pathologic complete response (PCR binary classification) and 5-year relapse-free survival status (RFS binary classification). Method: The proposed framework includes tumour segmentation, image registration, feature extraction, and predictive modelling. Using the image registration method, MRI image features can be extracted and compared from the original tumour site at different time points, therefore monitoring the intratumor changes during NACT process. Four feature extractors, including one radiomics and three deep learning-based (MedicalNet, Segformer3D, SAM-Med3D) were implemented and compared. In combination with three feature selection methods and four ML models, predictive models are built and compared. Results: The proposed image registration-based feature extraction consistently improves the predictive models. In the PCR and RFS classification tasks logistic regression model trained on radiomic features performed the best with an AUC of 0.88 and classification accuracy of 0.85 for PCR classification, and AUC of 0.78 and classification accuracy of 0.72 for RFS classification. Conclusions: It is evidenced that the image registration method has significantly improved performance in longitudinal feature learning in predicting PCR and RFS. The radiomics feature extractor is more effective than the pre-trained deep learning feature extractors, with higher performance and better interpretability.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>